Sign in
4

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0000921895-20-002547

Options or other derivatives

  • Chief Executive Officer acquired 9,730,539 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

DUGGAN ROBERT W · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-10-02 Grant or award : show line 1 in the form Common Stock +9,730,539 9,730,539 D
Loading xslF345X03/form412566002_10062020.xml…